Vital Farms Killed Its Buyback and Missed on Revenue in Q2 2026 — and VITL Rose Nearly 5% Anyway

Vital Farms' board terminated its share repurchase program on August 3, 2026, as a required condition of a new $60 million, three-year asset-based lending facility that replaced the company's previous revolving credit line — the new facility strengthens Vital Farms' liquidity profile, but its terms did not permit the company to keep buying back stock while drawing on it. Three days later, on August 6, the company reported second-quarter 2026 results showing revenue down 10.1% year over year to $166 million, though that figure still beat Wall Street's estimate by roughly 0.8%. Gross margin contracted sharply to 6.6% from 38.9% a year earlier, as an industry-wide egg oversupply pushed more volume through lower-priced channels and pressured input and production costs.

What makes this worth reading past the headline numbers is what management said alongside them. The company described the quarter as reflecting industry-wide oversupply and price pressure rather than company-specific execution failure, pointed to a recovery plan already lowering fixed overhead and right-sizing supply, and reaffirmed full-year 2026 guidance — a signal that management expects the trough to be temporary and margins to recover in the back half of the year.

VITL rose nearly 5% in the fifteen minutes after this combination of news landed on August 6, 2026. On paper, both individual pieces — losing buyback capacity and a sharp margin contraction — typically read as negative. The market's reaction suggests it weighted the reaffirmed guidance and recovery narrative more heavily than either of those two factors: the buyback termination was a lending-covenant trade-off for better liquidity, not a signal of financial distress, and a revenue beat plus unchanged full-year guidance told investors management still expects to hit its numbers despite the current oversupply cycle.